GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corline Biomedical AB (OSTO:CLBIO) » Definitions » Price-to-Owner-Earnings

Corline Biomedical AB (OSTO:CLBIO) Price-to-Owner-Earnings : (As of Jun. 04, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Corline Biomedical AB Price-to-Owner-Earnings?

As of today (2024-06-04), Corline Biomedical AB's share price is kr10.95. Corline Biomedical AB does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Corline Biomedical AB's Price-to-Owner-Earnings or its related term are showing as below:


OSTO:CLBIO's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 34.035
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-04), Corline Biomedical AB's share price is kr10.95. Corline Biomedical AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr-0.18. Therefore, Corline Biomedical AB's PE Ratio for today is At Loss.

As of today (2024-06-04), Corline Biomedical AB's share price is kr10.95. Corline Biomedical AB's EPS without NRI for the trailing twelve months (TTM) ended in was kr-0.18. Therefore, Corline Biomedical AB's PE Ratio without NRI for today is At Loss.

During the past 10 years, Corline Biomedical AB's highest PE Ratio without NRI was 348.33. The lowest was 0.00. And the median was 285.00.


Corline Biomedical AB Price-to-Owner-Earnings Historical Data

The historical data trend for Corline Biomedical AB's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corline Biomedical AB Price-to-Owner-Earnings Chart

Corline Biomedical AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Corline Biomedical AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Corline Biomedical AB's Price-to-Owner-Earnings

For the Biotechnology subindustry, Corline Biomedical AB's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Corline Biomedical AB's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Corline Biomedical AB's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Corline Biomedical AB's Price-to-Owner-Earnings falls into.



Corline Biomedical AB Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Corline Biomedical AB's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=10.95/-0.20
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Corline Biomedical AB  (OSTO:CLBIO) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Corline Biomedical AB Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Corline Biomedical AB's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Corline Biomedical AB (OSTO:CLBIO) Business Description

Traded in Other Exchanges
N/A
Address
Lefflersgatan 5, Uppsala, SWE, 754 50
Corline Biomedical AB is involved in developing, manufacturing and marketing heparin-based solutions to improve kidney transplantation, cell therapies, and applications in the field of regenerative medicine.

Corline Biomedical AB (OSTO:CLBIO) Headlines

No Headlines